Pharmaceutical companies urge prime ministerial candidates to increase R&D investment to reverse negative trends
A trade association representing 120 UK pharmaceutical companies has urged Rishi Sunak and Liz Truss to make UK life sciences “central” to their agenda if they become the next UK prime minister.
In a letter to the Conservative Party leadership candidates dated 31 July, Richard Torbett, the chief executive of the Association of the British Pharmaceutical Industry, warned that there are “real signs that the UK is slipping behind our global competitors in the race to become a life sciences superpower”.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.